When we look and analyze a schedule of a normal person, we will notice that the person is having one or the other disorder. One common disorder that is found in any ordinary person is the sleeping disorder. And in today’s era, 90% of people work in the IT sector. When it comes to IT […]
Ebola is been around us since last 40 years, with its deadly influence initiated in 2014 in the regions of West Africa. Its effects have shattered the social aspects of the society, as the infected person and their homes were isolated and marked in orange fencing. But practically, this way is the best way to […]
Meat, chicken, and other non-vegetarian foods are termed as protein-rich food. Have you ever though it has some limitations based on the cooking methods and storage conditions? And if the limitations are ignored, it may severely damage your body as well. Based on a long survey carried out by the researchers from French, it is […]
To hear that sugary sodas may have contributed to the obesity epidemic probably would not come as much of a surprise to most people. But there are some studies that also suggest sugary drinks—like sodas—do not, in fact, cause obesity. How can that be? To have two studies on the same subject yield nearly opposite […]
New research, released Tuesday, indicates that it could take upwards of 83 years to close the gender gap in the United States—and that is on all fronts: health, politics, education, and economics. The report was published in the 2016 Global Gender Gap Report, from World Economic Forum. The survey looked at the current gender gap […]
A large part of the medical industry is drug research. Sure, doctors have to know how to diagnose and effectively treat disease, but much of the money that exchanges hands in this business has to do with pharmaceutical sales. With that, though, those who research and develop treatments are constantly searching not only for the […]
Alabama Governor Robert Bentley announced today that the Alabama Medicaid Agency will restore payments to doctors at the levels they were before the recent cuts went into effect, in August. Of course, these payments were reduced as a result of an $85 million shortfall in Medicaid’s budget for the new fiscal year, starting on October […]
Shares of Amgen fell slightly—by 1.5 percent, to $170.90—this week on the report that its multiple myeloma drug—carfilzomib, under the brand name Kyprolis–did not outperform the competition in a head-to-head, late-stage study regarding efficacy on previously untreated patients. The United States Food and Drug Administration had already approved Kyprolis for multiple myeloma patients who had […]